<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for NLNK</title>
    <link />
    <description>Headlines for NewLink Genetics Corporation</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>NewLink Genetics Begins Phase 2 Indoximod Trial for Treatment of Metastatic Breast Cancer</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3463129/newlink-genetics-begins-phase-2-indoximod-trial-for-treatment-of-metastatic-breas.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 02 Apr 2013 07:02:59 GMT</pubDate>
    </item>
    <item>
      <title>A Comprehensive Look At Immunotherapy - Part 2</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1243661-a-comprehensive-look-at-immunotherapy-part-2.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 04 Mar 2013 10:04:44 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Stifel Nicolaus Raises PT to $21 on NewLink Genetics on Accelerated Patient Enrollment</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3382050/update-stifel-nicolaus-raises-pt-to-21-on-newlink-geneti.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 01 Mar 2013 12:45:41 GMT</pubDate>
    </item>
    <item>
      <title>NewLink Genetics' CEO Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1235051-newlink-genetics-ceo-discusses-q4-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 28 Feb 2013 15:39:01 GMT</pubDate>
    </item>
    <item>
      <title>5 Speculative Biotech Stocks With Catalysts Pending</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1220731-5-speculative-biotech-stocks-with-catalysts-pending.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 25 Feb 2013 09:50:56 GMT</pubDate>
    </item>
    <item>
      <title>Why NewLink Is Poised to Underperform</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/20/why-newlink-is-poised-to-underperform/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 20 Feb 2013 10:06:00 GMT</pubDate>
    </item>
    <item>
      <title>5 Stocks With Big Insider Buying</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/5-stocks-big-insider-buying.html-29.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 06 Feb 2013 12:23:00 GMT</pubDate>
    </item>
    <item>
      <title>At Facebook and LinkedIn, Company Insiders Are Selling Stock</title>
      <link>http://www.fool.com/news/xt/minyanville/www.minyanville.com/trading-and-investing/stocks/articles/fb-nlnk-gd-now-msft-aegr/2/6/2013/id/47927.aspx?source=itxwebtxt0000015</link>
      <author>Minyanville</author>
      <pubDate>Wed, 06 Feb 2013 11:35:00 GMT</pubDate>
    </item>
    <item>
      <title>JPMorgan Healthcare Conference 2013: Ultra-Orphan Drug Companies Lead The Way</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1160111-jpmorgan-healthcare-conference-2013-ultra-orphan-drug-companies-lead-the-way.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 06 Feb 2013 10:39:41 GMT</pubDate>
    </item>
    <item>
      <title>Top Insider Trades: FB NLNK GD NOW</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11833964/1/top-insider-trades-fb-nlnk-gd-now.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 06 Feb 2013 09:41:00 GMT</pubDate>
    </item>
    <item>
      <title>U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130130-000329&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Wed, 30 Jan 2013 09:02:00 GMT</pubDate>
    </item>
    <item>
      <title>U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130130-000198&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Wed, 30 Jan 2013 06:21:59 GMT</pubDate>
    </item>
    <item>
      <title>NewLink Genetics Corporation Announces Proposed Public Offering of Common Stock</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/01/3285379/newlink-genetics-corporation-announces-proposed-public-offering-of-common-stock.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 29 Jan 2013 16:19:12 GMT</pubDate>
    </item>
    <item>
      <title>Newlink Genetics' Pancreatic Cancer Vaccine Likely To Disappoint Investors In 2013</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1088241-newlink-genetics-pancreatic-cancer-vaccine-likely-to-disappoint-investors-in-2013.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 31 Dec 2012 10:07:12 GMT</pubDate>
    </item>
    <item>
      <title>4 Small Biotech Stocks That Should Continue With Large Returns In 2013</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1081291-4-small-biotech-stocks-that-should-continue-with-large-returns-in-2013.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 25 Dec 2012 05:04:22 GMT</pubDate>
    </item>
    <item>
      <title>7 Low-Price Biotechs With High Positive Equity</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1044931-7-low-price-biotechs-with-high-positive-equity.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 04 Dec 2012 16:48:32 GMT</pubDate>
    </item>
    <item>
      <title>4 Biotech Stocks With Large 2012 Gains Still Present Significant Upside - Revisited</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/909381-4-biotech-stocks-with-large-2012-gains-still-present-significant-upside-revisited.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 07 Oct 2012 11:41:56 GMT</pubDate>
    </item>
    <item>
      <title>Celgene CVR: Upside Into Abraxane Pancreatic Cancer Trial Data</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11717470/1/celgene-cvr-upside-into-abraxane-pancreatic-cancer-trial-data.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 25 Sep 2012 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>A Gold Mine In Biotechnology: The Companies Poised To Benefit</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/844281-a-gold-mine-in-biotechnology-the-companies-poised-to-benefit.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 04 Sep 2012 09:34:17 GMT</pubDate>
    </item>
    <item>
      <title>A Gold Mine In Biotechnology And The Companies Poised To Benefit</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/844281-a-gold-mine-in-biotechnology-and-the-companies-poised-to-benefit.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 04 Sep 2012 06:29:18 GMT</pubDate>
    </item>
  </channel>
</rss>
